Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report.

Literature DB >> 19949714

Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report.

R V H P Huijskes¹, K Hoogenberg, A C P Wiesfeld, M E J Pijl, I C van Gelder.

Abstract

Haemochromatosis is a disturbance in the iron metabolism leading to excessive accumulation of iron in various organs such as the liver, pancreas, joints, skin, pituitary, testes and heart, with the last mentioned leading to heart failure. In this report we describe a patient with serious heart failure, attributed to homozygosity for C282Y in the haemochromatosis (HFE) gene, in whom repetitive phlebotomies led to normalisation of left ventricular function. (Neth Heart J 2009;17:438-41.).

Entities: Chemical Disease Gene Mutation Species

Keywords: haemochromatosis; heart failure; phlebotomy

Year: 2009 PMID： 19949714 PMCID： PMC2779482 DOI： 10.1007/BF03086299

Source DB: PubMed Journal: Neth Heart J ISSN： 1568-5888 Impact factor: 2.380

16 in total

1. MR quantification of hepatic iron concentration.

Authors: José M Alústiza; José Artetxe; Agustín Castiella; Cristina Agirre; José I Emparanza; Pedro Otazua; Manuel García-Bengoechea; Jesús Barrio; Fernando Mújica; José A Recondo
Journal: Radiology Date: 2003-12-10 Impact factor: 11.105

2. Hemochromatosis and heart failure: presentation of a case with survival after three years' treatment by repeated venesection.

Authors: S J GROSBERG
Journal: Ann Intern Med Date: 1961-03 Impact factor: 25.391

3. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.

Authors: K K Steinberg; M E Cogswell; J C Chang; S P Caudill; G M McQuillan; B A Bowman; L M Grummer-Strawn; E J Sampson; M J Khoury; M L Gallagher
Journal: JAMA Date: 2001-05-02 Impact factor: 56.272

4. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.

Authors: M L Bassett; J W Halliday; R A Ferris; L W Powell
Journal: Gastroenterology Date: 1984-09 Impact factor: 22.682

5. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients.

Authors: N Milman; P Pedersen; T á Steig; K E Byg; N Graudal; K Fenger
Journal: Ann Hematol Date: 2001-10-11 Impact factor: 3.673

6. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

Authors: Ernest Beutler; Vincent J Felitti; James A Koziol; Ngoc J Ho; Terri Gelbart
Journal: Lancet Date: 2002-01-19 Impact factor: 79.321

7. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy.

Authors: N G Mahon; A S Coonar; S Jeffery; F Coccolo; J Akiyu; B Zal; R Houlston; G E Levin; C Baboonian; W J McKenna
Journal: Heart Date: 2000-11 Impact factor: 5.994

8. Hemochromatosis and iron-overload screening in a racially diverse population.

Authors: Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky
Journal: N Engl J Med Date: 2005-04-28 Impact factor: 91.245

Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report.

1. MR quantification of hepatic iron concentration.

2. Hemochromatosis and heart failure: presentation of a case with survival after three years' treatment by repeated venesection.

3. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.

4. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.

5. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients.

6. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

7. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy.

8. Hemochromatosis and iron-overload screening in a racially diverse population.

9. Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report.

10. Long-term survival in patients with hereditary hemochromatosis.

1. Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report.

2. Difficult diagnosis of cardiac haemochromatosis: a case report.